Harvard University licenses its nasal swab collection technology, developed at the Wyss Institute and Harvard Medical School, to Mass. startup Rhinostics
b'BOSTON, May 4, 2021 /PRNewswire/ --The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\'s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.
- b'BOSTON, May 4, 2021 /PRNewswire/ --The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\'s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.
- "We were trying to circumvent supply and performance limitations of swabs when I heard about the Wyss Institute\'s swab technology at a MASS CPR online event.
- Novak had independently thought about possibilities to solve the problem of automatically removing the swab from the sample collection device.
- The RHINOstic product is registered as Class I exempt medical device with the FDA and is available for purchase.